ClearPoint Neuro, Inc. (CLPT)
USD 11.31
(-6.8%)
USD 11.31
(-6.8%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 13.61 Million USD | 0.61% |
| 2022 | 13.53 Million USD | 19.84% |
| 2021 | 11.29 Million USD | 23.8% |
| 2020 | 9.12 Million USD | 23.51% |
| 2019 | 7.38 Million USD | 50.08% |
| 2018 | 4.92 Million USD | 9.81% |
| 2017 | 4.48 Million USD | 44.23% |
| 2016 | 3.1 Million USD | 19.19% |
| 2015 | 2.6 Million USD | 55.4% |
| 2014 | 1.67 Million USD | -33.16% |
| 2013 | 2.5 Million USD | -44.27% |
| 2012 | 4.5 Million USD | 42.41% |
| 2011 | 3.16 Million USD | 19.17% |
| 2010 | 2.65 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 4.98 Million USD | 10.23% |
| 2024 Q1 | 4.52 Million USD | 12.76% |
| 2023 Q4 | 4.01 Million USD | 22.61% |
| 2023 Q1 | 3.2 Million USD | -3.44% |
| 2023 Q3 | 3.27 Million USD | 4.7% |
| 2023 Q2 | 3.12 Million USD | -2.37% |
| 2023 FY | 13.61 Million USD | 0.61% |
| 2022 Q3 | 3.71 Million USD | 13.97% |
| 2022 Q4 | 3.31 Million USD | -10.67% |
| 2022 Q1 | 3.24 Million USD | -1.31% |
| 2022 Q2 | 3.25 Million USD | 0.34% |
| 2022 FY | 13.53 Million USD | 19.84% |
| 2021 Q2 | 2.29 Million USD | -12.39% |
| 2021 FY | 11.29 Million USD | 23.8% |
| 2021 Q4 | 3.28 Million USD | 6.51% |
| 2021 Q1 | 2.61 Million USD | 14.45% |
| 2021 Q3 | 3.08 Million USD | 34.85% |
| 2020 Q2 | 1.83 Million USD | -16.43% |
| 2020 Q1 | 2.19 Million USD | -3.48% |
| 2020 Q4 | 2.28 Million USD | -18.44% |
| 2020 Q3 | 2.8 Million USD | 52.45% |
| 2020 FY | 9.12 Million USD | 23.51% |
| 2019 Q3 | 1.94 Million USD | 23.37% |
| 2019 Q4 | 2.27 Million USD | 17.13% |
| 2019 FY | 7.38 Million USD | 50.08% |
| 2019 Q1 | 1.58 Million USD | -0.09% |
| 2019 Q2 | 1.57 Million USD | -0.63% |
| 2018 Q2 | 1.04 Million USD | 0.94% |
| 2018 FY | 4.92 Million USD | 9.81% |
| 2018 Q4 | 1.58 Million USD | 26.61% |
| 2018 Q1 | 1.03 Million USD | 1.37% |
| 2018 Q3 | 1.25 Million USD | 20.09% |
| 2017 Q3 | 1.02 Million USD | -12.68% |
| 2017 FY | 4.48 Million USD | 44.23% |
| 2017 Q1 | 1.25 Million USD | 30.94% |
| 2017 Q2 | 1.17 Million USD | -6.15% |
| 2017 Q4 | 1.02 Million USD | -0.76% |
| 2016 Q3 | 868.02 Thousand USD | 48.92% |
| 2016 Q2 | 582.89 Thousand USD | -16.44% |
| 2016 Q1 | 697.58 Thousand USD | -19.34% |
| 2016 FY | 3.1 Million USD | 19.19% |
| 2016 Q4 | 958.18 Thousand USD | 10.39% |
| 2015 FY | 2.6 Million USD | 55.4% |
| 2015 Q4 | 864.8 Thousand USD | 26.06% |
| 2015 Q3 | 686.04 Thousand USD | 59.2% |
| 2015 Q2 | 430.92 Thousand USD | -31.03% |
| 2015 Q1 | 624.79 Thousand USD | 126.23% |
| 2014 Q3 | 317.35 Thousand USD | -48.14% |
| 2014 Q1 | 471.84 Thousand USD | -26.61% |
| 2014 Q4 | 276.17 Thousand USD | -12.97% |
| 2014 FY | 1.67 Million USD | -33.16% |
| 2014 Q2 | 611.96 Thousand USD | 29.7% |
| 2013 Q4 | 642.88 Thousand USD | 14.4% |
| 2013 FY | 2.5 Million USD | -44.27% |
| 2013 Q1 | 1.03 Million USD | -38.9% |
| 2013 Q2 | 266.71 Thousand USD | -74.3% |
| 2013 Q3 | 561.96 Thousand USD | 110.7% |
| 2012 Q4 | 1.69 Million USD | 70.14% |
| 2012 Q2 | 927 Thousand USD | 5.54% |
| 2012 Q1 | 878.33 Thousand USD | -5.47% |
| 2012 FY | 4.5 Million USD | 42.41% |
| 2012 Q3 | 998.45 Thousand USD | 7.71% |
| 2011 FY | 3.16 Million USD | 19.17% |
| 2011 Q3 | 846.88 Thousand USD | 22.3% |
| 2011 Q4 | 929.12 Thousand USD | 9.71% |
| 2011 Q2 | 692.49 Thousand USD | 0.0% |
| 2010 FY | 2.65 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 2.55 Million USD | -433.882% |
| BrainsWay Ltd. | 23.09 Million USD | 41.042% |
| Cerus Corporation | 86.4 Million USD | 84.243% |
| Envoy Medical, Inc. | -473 Thousand USD | 2978.224% |
| electroCore, Inc. | 13.22 Million USD | -2.934% |
| Helius Medical Technologies, Inc. | 61 Thousand USD | -22218.033% |
| IceCure Medical Ltd | 1.3 Million USD | -947.231% |
| Inogen, Inc. | 126.69 Million USD | 89.255% |
| OrthoPediatrics Corp. | 111.25 Million USD | 87.763% |
| Lucid Diagnostics Inc. | -6.05 Million USD | 325.025% |
| Monogram Orthopaedics, Inc. | -47.33 Thousand USD | 28860.352% |
| MaxCyte, Inc. | 36.54 Million USD | 62.748% |
| NeuroOne Medical Technologies Corporation | 456.51 Thousand USD | -2882.145% |
| Nexalin Technology, Inc. | 85.06 Thousand USD | -15905.173% |
| Orthofix Medical Inc. | 486.27 Million USD | 97.2% |
| PAVmed Inc | -3.96 Million USD | 443.095% |
| Rapid Micro Biosystems, Inc. | -5.48 Million USD | 348.204% |
| RxSight, Inc. | 53.76 Million USD | 74.679% |
| Sight Sciences, Inc. | 69.17 Million USD | 80.319% |
| SI-BONE, Inc. | 109.42 Million USD | 87.558% |
| TELA Bio, Inc. | 40.11 Million USD | 66.06% |
| Treace Medical Concepts, Inc. | 151.93 Million USD | 91.04% |
| Vivos Therapeutics, Inc. | 8.27 Million USD | -64.599% |
| Acutus Medical, Inc. | -3.13 Million USD | 533.982% |
| Talis Biomedical Corporation | 371 Thousand USD | -3569.542% |
| Spectral AI, Inc. | 7.88 Million USD | -72.766% |
| Nano-X Imaging Ltd. | -6.59 Million USD | 306.523% |
| CVRx, Inc. | 33.03 Million USD | 58.794% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| PetVivo Holdings, Inc. | 739.52 Thousand USD | -1740.909% |
| Bioventus Inc. | 328.19 Million USD | 95.852% |
| Venus Concept Inc. | 52.16 Million USD | 73.903% |
| TriSalus Life Sciences, Inc. | 15.9 Million USD | 14.41% |
| LivaNova PLC | 771.25 Million USD | 98.235% |
| 908 Devices Inc. | 25.32 Million USD | 46.236% |
| Alphatec Holdings, Inc. | 310.2 Million USD | 95.611% |
| Nemaura Medical Inc. | -1.47 Million USD | 1022.113% |
| NeuroPace, Inc. | 48.12 Million USD | 71.709% |
| LENSAR, Inc. | 21.1 Million USD | 35.5% |
| Apyx Medical Corporation | 14.12 Million USD | 3.597% |
| Cutera, Inc. | 41.49 Million USD | 67.19% |
| STRATA Skin Sciences, Inc. | 18.46 Million USD | 26.255% |
| BioSig Technologies, Inc. | 18 Thousand USD | -75533.333% |
| Anika Therapeutics, Inc. | 103.08 Million USD | 86.794% |
| Integra LifeSciences Holdings Corporation | 888.39 Million USD | 98.468% |
| Axonics, Inc. | 274.55 Million USD | 95.041% |
| Outset Medical, Inc. | 29 Million USD | 53.055% |
| IRIDEX Corporation | 21.8 Million USD | 37.571% |
| PROCEPT BioRobotics Corporation | 71.04 Million USD | 80.839% |
| IRadimed Corporation | 50.15 Million USD | 72.858% |
| Tivic Health Systems, Inc. | 287 Thousand USD | -4643.554% |
| INVO Bioscience, Inc. | 1.08 Million USD | -1153.432% |
| Telesis Bio, Inc. | 16.95 Million USD | 19.681% |
| Viemed Healthcare, Inc. | 112.78 Million USD | 87.929% |
| Varex Imaging Corporation | 256.9 Million USD | 94.701% |
| Quipt Home Medical Corp. | 163.84 Million USD | 91.691% |
| Inspira Technologies Oxy B.H.N. Ltd. | -406 Thousand USD | 3453.202% |
| Pulmonx Corporation | 50.75 Million USD | 73.175% |
| Dynatronics Corporation | 7.63 Million USD | -78.311% |
| Modular Medical, Inc. | -768 Thousand USD | 1872.656% |
| ReShape Lifesciences Inc. | 5.54 Million USD | -145.386% |
| Semler Scientific, Inc. | 61.2 Million USD | 77.755% |
| InMode Ltd. | 411.34 Million USD | 96.69% |
| Bruker Corporation | 1.51 Billion USD | 99.102% |
| Cytosorbents Corporation | 22.39 Million USD | 39.202% |
| DexCom, Inc. | 2.28 Billion USD | 99.405% |
| Align Technology, Inc. | 2.71 Billion USD | 99.499% |
| Viveve Medical, Inc. | 620 Thousand USD | -2095.806% |
| ZimVie Inc. | 290.38 Million USD | 95.312% |
| Movano Inc. | -158 Thousand USD | 8716.456% |
| Cytek Biosciences, Inc. | 109.42 Million USD | 87.559% |
| Nexalin Technology, Inc. | 85.06 Thousand USD | -15905.173% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 367.69 Million USD | 96.297% |
| Profound Medical Corp. | 4.51 Million USD | -201.594% |
| Insulet Corporation | 1.15 Billion USD | 98.826% |
| enVVeno Medical Corporation | -546 Thousand USD | 2593.407% |
| Surmodics, Inc. | 93.05 Million USD | 85.369% |
| iCAD, Inc. | 14.53 Million USD | 6.343% |
| Nuwellis, Inc. | 4.98 Million USD | -173.209% |
| Biotricity, Inc. | 8.35 Million USD | -62.919% |
| iRhythm Technologies, Inc. | 331.8 Million USD | 95.897% |
| Aethlon Medical, Inc. | -359.05 Thousand USD | 3891.599% |
| InspireMD, Inc. | 1.8 Million USD | -653.403% |
| PAVmed Inc. | -3.96 Million USD | 443.095% |
| BIOLASE, Inc. | 16.72 Million USD | 18.596% |
| Beyond Air, Inc. | -1.3 Million USD | 1141.622% |
| FONAR Corporation | 45.14 Million USD | 69.841% |
| AxoGen, Inc. | 127.87 Million USD | 89.354% |
| Vivani Medical, Inc. | -357 Thousand USD | 3913.445% |
| Tactile Systems Technology, Inc. | 195.13 Million USD | 93.023% |
| Inari Medical, Inc. | 434.56 Million USD | 96.867% |
| UFP Technologies, Inc. | 112.22 Million USD | 87.869% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 12.51 Thousand USD | -108646.705% |
| Tenon Medical, Inc. | 1.24 Million USD | -997.019% |
| Autonomix Medical, Inc. Common Stock | -81 Thousand USD | 16907.407% |
| Co-Diagnostics, Inc. | 2.62 Million USD | -418.216% |
| AdaptHealth Corp. | 479.56 Million USD | 97.161% |
| Sintx Technologies, Inc. | 1.84 Million USD | -638.687% |
| NanoVibronix, Inc. | 1.53 Million USD | -785.751% |
| Quanterix Corporation | 70.64 Million USD | 80.729% |
| Inspira Technologies Oxy B.H.N. Ltd. | -406 Thousand USD | 3453.202% |
| Sensus Healthcare, Inc. | 14.06 Million USD | 3.172% |
| Pacific Biosciences of California, Inc. | 52.78 Million USD | 74.206% |
| TransMedics Group, Inc. | 154.09 Million USD | 91.165% |
| ReWalk Robotics Ltd. | 4.45 Million USD | -205.726% |
| NeuroMetrix, Inc. | 3.94 Million USD | -244.884% |
| Hyperfine, Inc. | 4.75 Million USD | -186.189% |
| Establishment Labs Holdings Inc. | 106.97 Million USD | 87.274% |
| Biomerica, Inc. | 611 Thousand USD | -2128.151% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 41.68 Million USD | 67.343% |
| Bluejay Diagnostics, Inc. | -780.95 Thousand USD | 1843.25% |
| Silk Road Medical, Inc | 127.08 Million USD | 89.288% |